Skip to content

Work Productivity in Hyperventilation Syndrome

Work Productivity in Hyperventilation Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03292523
Acronym
WHY
Enrollment
50
Registered
2017-09-25
Start date
2018-02-06
Completion date
2021-02-23
Last updated
2022-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperventilation Syndrome

Keywords

Hyperventilation syndrome, Work productivity, Absenteeism, Presenteeism

Brief summary

Hyperventilation syndrome is associated with impaired quality of life. The aim of the study is to assess the relationship between work productivity, including absenteeism and presenteeism, and the severity of hyperventilation syndrome

Interventions

OTHERquestionnaire

Work Productivity and Activity Impairment (WPAI) Multidimensional Dyspnea Profile (MDP) Baseline Dyspnea Index (BDI), MOS-SF36, Hospital Anxiety Depression (HAD) Cognitive Failure Questionnaire (CFQ).

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Holders of employment contracts for at least 8 days * Diagnosis of hyperventilation syndrome confirmed by: Compatible symptoms and at least two symptoms reproduced by the hyperventilation challenge test: Nijmegen's score\> 23 ; Demonstration of alveolar hyperventilation ( Either on rest blood and / or at rest (PaCO2 at rest \<36 mmHg and D (A-a) O2 normal; Either during the HV test (increased recovery time of the basic PETCO2 after voluntary hyperventilation (greater than 5 minutes)

Exclusion criteria

* Existence of another chronic pulmonary disease (asthma, bronchial dilation, COPD, diffuse interstitial pneumonia, neuromuscular pathology ...) or cardiac (rhythm disorder, ischemic heart disease ...) which can participate in dyspnea * Psychiatric illness / psychotropic treatment * Pregnancy * Patient already included in a clinical research protocol involving new therapeutics may not be included in this protocol * Specific physiotherapy or previous training

Design outcomes

Primary

MeasureTime frame
Association between the WPAI score and the Nijmegen scoreAt the time of diagnosis (Baseline)

Secondary

MeasureTime frame
Association between the WPAI score and dyspnea scalesAt the time of diagnosis (Baseline)
Association between the WPAI score and quality of life scoresAt the time of diagnosis (Baseline)
Association between the WPAI score and PaCO2At the time of diagnosis (Baseline)
Association between the WPAI score and the Cognitive Failure Questionnaire scoreAt the time of diagnosis (Baseline)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026